Teradyne Reports First Quarter 2021 Results
(1 | ) | Restructuring and other consists of: | | | | | |
| | | |
Quarter Ended |
| | | |
April 4, 2021 | |
December 31, 2020 | |
March 29, 2020 |
| | Contingent consideration fair value adjustment | $ | (7.2 | ) | | $ | (15.3 | ) | | $ | (10.0 | ) |
| | Acquisition related expenses and compensation | | (0.2 | ) | | | (0.9 | ) | | | 1.4 | |
| | Employee severance | | 0.2 | | | | 1.1 | | | | 0.7 | |
| | Other | | | 0.1 | | | | - | | | | 0.3 | |
| | | | $ | (7.1 | ) | | $ | (15.1 | ) | | $ | (7.6 | ) |
| | | | | | | | |
| | | | | | | | |
(2 | ) | For the quarters ended April 4, 2021, December 31 2020, and March 29, 2020, Interest and other expense included non-cash convertible debt interest expense. For the quarter ended April 4, 2021, adjustment to exclude loss on convertible debt conversions. For the quarter ended December 31 2020, adjustments to exclude actuarial (gain) loss recognized under GAAP in accordance with Teradyne's mark-to-market pension accounting. |
| | | | | | | | |
(3 | ) | For the quarters ended April 4, 2021, December 31, 2020, and March 29, 2020, the non-GAAP diluted EPS calculation adds back $1.2 million, $1.3 million, and $1.3 million of convertible debt interest expense to non-GAAP net income, and non-GAAP weighted average diluted common shares include 9.4 million, 8.9 million and 5.5 million shares, respectively, from the convertible note hedge transaction. |